Creighton University

creighton.edu

Total trials

126

Active

5

Phase 3

5

Total enrollment

21,193

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 0 of 0 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal

Next readouts

No upcoming readouts found.

Top conditions

  • Vitamin D Deficiency8
  • Osteoporosis7
  • Asthma5
  • Atrial Fibrillation5
  • Hypertension4
  • Post-Traumatic Stress Disorder4
  • Maternal-Fetal Relations4
  • Bipolar Disorder3

Frequently asked questions about Creighton University

How many clinical trials does Creighton University have on ClinicalTrials.gov?
Creighton University is listed as the lead sponsor on 126 clinical trials in ClinicalTrials.gov, 5 of which are currently active (recruiting, enrolling, or ongoing).
How many of Creighton University's trials are in Phase 3?
5 of Creighton University's trials are in Phase 3.
What therapeutic areas does Creighton University focus on?
Creighton University's most-studied conditions on ClinicalTrials.gov are Vitamin D Deficiency, Osteoporosis, Asthma, Atrial Fibrillation, Hypertension.